Back

Notification report


Full notification file


General information

Notification Number
B/NL/06/009

Member State to which the notification was sent
Netherlands

Date of acknowledgement from the Member State Competent Authority
01/05/2006

Title of the Project
An open-label phase I study to evaluate the safety of the HIV-1 vaccine MVA-B in chronic HIV-1 infected patients successfully treated with HAART

Proposed period of release:
01/12/2006 to 31/12/2008

Name of the Institute(s) or Company(ies)
Academic Medical Center, Amsterdam;


3. Is the same GMO release planned elsewhere in the Community?
Yes:
Germany; France;

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
MVA-BorthopoxvirusvacciniaModified Virus Ankara

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known